Surgical KIS

Company Overview

Snapshot

Founded in June 2023 by Uri Blumenthal and Amit Ashkenazi, Surgical KIS operates with 1–10 employees. The company has secured funding across one round. In January 2024, Surgical KIS received seed funding from Youdim Pharmaceuticals.

Business overview

Surgical KIS is developing the SLEEK suture, an innovative system designed to enhance the efficiency, speed, and precision of attaching artificial heart valves to heart tissues. This system aims to offer a user-friendly, cost-effective, and metal-free alternative to conventional manual methods. The company operates within the Health Tech & Life Sciences sector, specifically focusing on Medical Devices and Assistive Devices, targeting healthcare providers.

Company Intelligence Q&A

When was Surgical KIS founded?

Surgical KIS was founded in June 2023.

Who are the founders of Surgical KIS?

The co-founders of Surgical KIS are Uri Blumenthal and Amit Ashkenazi.

What is the primary product developed by Surgical KIS?

Surgical KIS is developing the SLEEK suture, an innovative system for attaching artificial heart valves to heart tissues.

Which investor participated in Surgical KIS's seed funding round?

In January 2024, Surgical KIS received seed funding from Youdim Pharmaceuticals.

What problem does the SLEEK suture aim to solve?

The SLEEK suture aims to provide a more efficient, quicker, and precise method for surgeons to attach artificial heart valves compared to conventional manual techniques, while also being user-friendly, cost-effective, and free of metallic components.